Damora Therapeutics, Inc. - 8-K Filing
Damora Therapeutics completed redomestication from Delaware to Cayman Islands on July 16, 2026 (Items: 1.01 Entry into a Material Definitive Agreement, 3.03 Material Modification to Rights of Security Holders, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 7.01 Regulation FD Disclosure)
Tickers: $GLTO